ArticleCancer research communications2025

Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Benjamin T Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.